photo walkheader_zpsd5bunpmi.png

Category Archives: Pancreatic Cancer

SOX Chemo Regimen as 2nd Line for Pancreatic Cancer

Acronyms in medicine are often a hoot.  We have the four-drug combination called FOLFIRINOX for advanced pancreatic cancer (ductal adenocarcinoma of the pancreas).  Recently, here at Pancreatica we reported on a study of a three-drug version of the above termed: OFF.   Now comes a review of the regimen of S-1 plus oxaliplatin by Japanese researchers, […]

DNA Epigenetic Changes for the Earlier Diagnosis of Pancreatic Cancer

In an absolutely remarkable, fascinating and possible game-changing study, Joo Mi Yi and Nita Ahuja and colleagues (primarily) from Johns Hopkins University have identified a “panel” of biomarkers based on DNA methylation of two relatively obscure genes (that can be identified in serum) for use, at least at an experimental level at this stage, for […]

Tarceva Plus Gemcitabine After Surgery for Pancreatic Cancer ?

Gress and colleagues from the University of Marburg in Germany published the results of a Phase II trial in the October 2013 issue of the Annals of Oncology, the official journal of the European Society for Medical Oncology. They did a prospective multi-center study of 76 pancreatic cancer (ductal adenocarcinoma of the pancreas) patients over […]

Page 18 of 37« First...10...1617181920...30...Last »
Facebook
Facebook